BriaCell Therapeutics Statistics
Total Valuation
TSX:BCT has a market cap or net worth of CAD 27.58 million. The enterprise value is 19.78 million.
Market Cap | 27.58M |
Enterprise Value | 19.78M |
Important Dates
The next estimated earnings date is Monday, June 9, 2025.
Earnings Date | Jun 9, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
TSX:BCT has 6.12 million shares outstanding. The number of shares has increased by 58.67% in one year.
Current Share Class | 6.12M |
Shares Outstanding | 6.12M |
Shares Change (YoY) | +58.67% |
Shares Change (QoQ) | +52.00% |
Owned by Insiders (%) | 7.45% |
Owned by Institutions (%) | 1.93% |
Float | 5.12M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | 5.91 |
P/TBV Ratio | 5.59 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -1.18 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -0.61 |
Financial Position
The company has a current ratio of 1.37
Current Ratio | 1.37 |
Quick Ratio | 1.37 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -158.14% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | -661.06% |
Revenue Per Employee | n/a |
Profits Per Employee | -1.05M |
Employee Count | 16 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -85.61% in the last 52 weeks. The beta is 1.80, so TSX:BCT's price volatility has been higher than the market average.
Beta (5Y) | 1.80 |
52-Week Price Change | -85.61% |
50-Day Moving Average | 5.35 |
200-Day Moving Average | 10.76 |
Relative Strength Index (RSI) | 44.16 |
Average Volume (20 Days) | 13,801 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -39.54M |
Pretax Income | -16.97M |
Net Income | -16.78M |
EBITDA | -39.35M |
EBIT | -39.54M |
Earnings Per Share (EPS) | -10.01 |
Balance Sheet
The company has 7.26 million in cash and n/a in debt, giving a net cash position of 7.26 million or 1.19 per share.
Cash & Cash Equivalents | 7.26M |
Total Debt | n/a |
Net Cash | 7.26M |
Net Cash Per Share | 1.19 |
Equity (Book Value) | 4.67M |
Book Value Per Share | 1.77 |
Working Capital | 2.80M |
Cash Flow
In the last 12 months, operating cash flow was -31.83 million and capital expenditures -661,133, giving a free cash flow of -32.49 million.
Operating Cash Flow | -31.83M |
Capital Expenditures | -661,133 |
Free Cash Flow | -32.49M |
FCF Per Share | -5.31 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
TSX:BCT does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -58.67% |
Shareholder Yield | n/a |
Earnings Yield | -60.83% |
FCF Yield | -117.82% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on January 29, 2025. It was a reverse split with a ratio of 0.0666667.
Last Split Date | Jan 29, 2025 |
Split Type | Reverse |
Split Ratio | 0.0666667 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |